Paroxetine Hydrochloride
Who holds supplier records for Paroxetine Hydrochloride? 17 organisations hold a current record for Paroxetine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), China (3), Spain (1), Canada (1) and 2 other countries (2); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Paroxetine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/paroxetine-hydrochloride
Reading the evidence
- 17 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (17)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Paroxetine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 19152 · latest filing Jan 2006
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 22337 · latest filing Mar 2009
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 38793 · latest filing Sept 2023
- MEDICHEM SASpainCEP Company GMP cert on recordActive DMF 18052 · latest filing Feb 2005
- WANBURY LTDIndiaCEPActive DMF 20248 · latest filing Dec 2006
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 19922 · latest filing Oct 2006
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 16680 · latest filing Jun 2003
- Apotex Inc.CanadaActive DMF 21440 · latest filing Mar 2008
- GLAXOSMITHKLINEActive DMF 14475, 15039 · latest filing Sept 2000
- Orchid Pharma LimitedIndia Company GMP cert on recordActive DMF 19751 · latest filing Sept 2006
- Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.ChinaActive DMF 40325 · latest filing Aug 2024
- SIGNA SA DE CVActive DMF 28763 · latest filing Dec 2014
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 19178 · latest filing Feb 2006
- Zhejiang Haisen Pharmaceutical Co., Ltd.ChinaActive DMF 43345 · latest filing Dec 2025
- ItalyCEP Company GMP cert on record
- HungaryCEP Company GMP cert on record
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordInactive DMF 21007 · latest filing Apr 2008
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (10)
Certificates of Suitability on the EDQM register for Paroxetine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 16 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2006-206 - Rev 06 Paroxetine hydrochloride hemihydrate | Jun 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2009-155 - Rev 07 Paroxetine hydrochloride | Jun 2026 | — |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2014-095 - Rev 01 Paroxetine hydrochloride hemihydrate | May 2026 | — |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2009-204 - Rev 03 Paroxetine hydrochloride hemihydrate | Jan 2026 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | CEP 2004-239 - Rev 07 Paroxetine hydrochloride hemihydrate | Oct 2024 | — |
| GEDEON RICHTER PLC. Budapest | HU | R1-CEP 2003-250 - Rev 02 Paroxetine hydrochloride hemihydrate | Jul 2022 | — |
| CHEMI S.P.A. Patrica | IT | R1-CEP 2011-188 - Rev 02 Paroxetine hydrochloride hemihydrate | Jun 2020 | — |
| Wanbury Limited Vashi, Navi Mumbai | IN | R1-CEP 2012-376 - Rev 00 Paroxetine hydrochloride hemihydrate | Mar 2019 | — |
| Medichem, S.A. Sant Joan Despí | ES | R1-CEP 2011-200 - Rev 00 Paroxetine hydrochloride hemihydrate | Mar 2018 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R1-CEP 2006-192 - Rev 01 Paroxetine hydrochloride hemihydrate | Jun 2017 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (10)
Organisations whose Type II DMFs for Paroxetine Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 10 historical records
- United Kingdom · Inactive DMF 24960, 14913 · filed May 2011
- India · Inactive DMF 19970 · filed Nov 2006
- TAIZHOU HIGHSUN PHARMACEUTICAL CO LTDInactive DMF 19803 · filed Sept 2006
- India · Inactive DMF 17286 · filed Apr 2004
- RECORDATI ESPANA SLInactive DMF 17293 · filed Mar 2004
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 16416 · filed Feb 2003
- Brazil · Inactive DMF 16247 · filed Nov 2002
- ASAHI GLASS CO LTDInactive DMF 14432 · filed Sept 1999
- Japan · Inactive DMF 13888 · filed Dec 1998
- APOTEX PHARMACHEM INCInactive DMF 12770 · filed Dec 1997
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Paroxetine Hydrochloride is a selective serotonin reuptake inhibitor (SSRI) used to treat major depressive disorder and a range of anxiety disorders. It improves mood by increasing the levels of serotonin, a natural substance in the brain that helps maintain mental balance.
Chemical identity
- IUPAC name
- bis((3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine);hydrate;dihydrochloride
- Canonical SMILES
- C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.O.Cl.Cl
- InChIKey
- MQZOATSIFWSKKT-OASXIEIISA-N
- Synonyms
- Paxil API, aropax, brl29060a, deroxat, paroxetine hydrochloride hemihydrate, paroxetine hydrochloride hydrate, paxil, paxil cr, seroxat
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Serotonin Reuptake Inhibitor
- Mechanism of action
- Serotonin Uptake Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Paroxetine Hydrochloride?
17 organisations hold an active US FDA Type II Drug Master File or a CEP for Paroxetine Hydrochloride: APITORIA PHARMA PRIVATE LTD (India), JUBILANT BIOSYS LTD (India), MATRIX PHARMACORP PRIVATE LTD (India), MEDICHEM SA (Spain), WANBURY LTD (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), Zydus Lifesciences Limited (India) and Apotex Inc. (Canada), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Paroxetine Hydrochloride Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 19152), JUBILANT BIOSYS LTD (DMF 22337), MATRIX PHARMACORP PRIVATE LTD (DMF 38793), MEDICHEM SA (DMF 18052), WANBURY LTD (DMF 20248), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 19922), Zydus Lifesciences Limited (DMF 16680) and Apotex Inc. (DMF 21440) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Paroxetine Hydrochloride records mean?
10 organisations have only inactive Type II DMFs for Paroxetine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Paroxetine Hydrochloride have a European Certificate of Suitability?
Yes. 10 organisations hold a valid CEP for Paroxetine Hydrochloride on the EDQM register, including APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), IPCA LABORATORIES LIMITED Mumbai (IN), JUBILANT BIOSYS LIMITED Mysuru (IN), ZYDUS LIFESCIENCES LIMITED Vadodara (IN) and GEDEON RICHTER PLC. Budapest (HU) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Paroxetine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Paroxetine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.